NLS Pharmaceutics AG: NLS Pharmaceutics Appoints Chad C. Hellmann as Chief Financial Officer

ZURICH, SWITZERLAND / ACCESSWIRE / June 6, 2022 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP),(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery

Related Keywords

United States ,Zurich ,Züsz ,Switzerland ,Chad ,Swiss ,Alex Zwyer ,Subhasis Roy ,Cindy Rizzo ,Pascal Nigen ,Vertebron Inc ,Yachtstore Ltd ,Nuvision Inc ,Nasdaq ,Pharmaceutics Ltd ,Exchange Commission ,Water Inc ,Alpha Bronze ,Chief Financial Officer ,Marcus Ventures ,Chief Executive Officer ,Rosebank Capital Partners ,Cat Trail Management ,Cat Trail Capital ,Bison Ventures ,Mazindol Controlled Release ,Orphan Drug Designations ,Pharmaceutics ,Ppoints ,Hellmann ,Chief ,Financial ,Officer ,